Efficacy, Safety, and Withdrawal and Retreatment With Brodalumab in Moderate to Severe Plaque Psoriasis Subjects
Public ClinicalTrials.gov record NCT01708590. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Study to Evaluate the Efficacy, Safety, and Effect of Withdrawal and Retreatment With Brodalumab in Subjects With Moderate to Severe Plaque Psoriasis: AMAGINE-1
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the safety and efficacy of brodalumab taken every two weeks at two different doses.
Study identification
- NCT ID
- NCT01708590
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 661 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2012
- Primary completion
- Apr 30, 2014
- Completion
- Jul 31, 2015
- Last update posted
- Jan 2, 2020
2012 – 2015
United States locations
- U.S. sites
- 33
- U.S. states
- 17
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Phoenix | Arizona | 85023 | — |
| Research Site | Bakersfield | California | 93301 | — |
| Research Site | Encino | California | 91436 | — |
| Research Site | Los Angeles | California | 90045 | — |
| Research Site | San Diego | California | 92123 | — |
| Research Site | San Francisco | California | 94118 | — |
| Research Site | San Ramon | California | 94583 | — |
| Research Site | Santa Monica | California | 90404 | — |
| Research Site | Alpharetta | Georgia | 30022 | — |
| Research Site | West Dundee | Illinois | 60118 | — |
| Research Site | Richmond | Kentucky | 40475 | — |
| Research Site | Columbia | Maryland | 21045 | — |
| Research Site | Boston | Massachusetts | 02111 | — |
| Research Site | Fort Gratiot | Michigan | 48059 | — |
| Research Site | St Louis | Missouri | 63104 | — |
| Research Site | St Louis | Missouri | 63117 | — |
| Research Site | St Louis | Missouri | 63141 | — |
| Research Site | Omaha | Nebraska | 68131 | — |
| Research Site | Buffalo | New York | 14221 | — |
| Research Site | Forest Hills | New York | 11375 | — |
| Research Site | Rochester | New York | 14618 | — |
| Research Site | Stony Brook | New York | 11790 | — |
| Research Site | Wilmington | North Carolina | 28401 | — |
| Research Site | Cleveland | Ohio | 44106 | — |
| Research Site | Portland | Oregon | 97223 | — |
| Research Site | Rapid City | South Dakota | 57702 | — |
| Research Site | Goodlettsville | Tennessee | 37072 | — |
| Research Site | Nashville | Tennessee | 37215 | — |
| Research Site | Arlington | Texas | 76011 | — |
| Research Site | Austin | Texas | 78759 | — |
| Research Site | Dallas | Texas | 75231 | — |
| Research Site | Houston | Texas | 77030 | — |
| Research Site | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 45 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01708590, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 2, 2020 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01708590 live on ClinicalTrials.gov.